Last data update: May 20, 2022. (Total: 3839 publications since 2011)
|Query Trace: all>>Lauren S Cowan[CDC Author]|
| Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Patricia J Campbell, Glenn P Morlock, R David Sikes, Tracy L Dalton, Beverly Metchock, Angela M Starks, Delaina P Hooks, Lauren S Cowan, Bonnie B Plikaytis, and James E Posey
Antimicrobial agents and chemotherapy 2011 May 55(5) 2032-41
Similar articles in PubMed DOI:10.1128/AAC.01550-10
| Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
Justin L Kandler, Alexandra D Mercante, Tracy L Dalton, Matthew N Ezewudo, Lauren S Cowan, Scott P Burns, Beverly Metchock, , Peter Cegielski, and James E Posey
Antimicrobial agents and chemotherapy 2018 Aug
Similar articles in PubMed DOI:10.1128/AAC.00974-18
| Statistical Method to Detect Tuberculosis Outbreaks among Endemic Clusters in a Low-Incidence Setting.
Sandy P Althomsons, Andrew N Hill, Alexia V Harrist, Anne Marie France, Krista M Powell, James E Posey, Lauren S Cowan, and Thomas R Navin
Emerging infectious diseases 2018 Mar (3) 573-575
Similar articles in PubMed DOI:10.3201/eid2403.171613
| Using genotyping and geospatial scanning to estimate recent mycobacterium tuberculosis transmission, United States.
Patrick K Moonan, Smita Ghosh, John E Oeltmann, J Steven Kammerer, Lauren S Cowan, and Thomas R Navin
Emerging Infect. Dis. 2012 Mar 18(3) 458-65
Similar articles in PubMed DOI:10.3201/eid1803.111107